Maen Abdelrahim

Oncology

6445 Main St Fl 24
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Real-world analysis of ctDNA and other biomarkers in patients with curatively resected stage I-III biliary tract cancer.

Journal: ESMO gastrointestinal oncology

Published: August 12, 2026

"How I Do it": Caring for Solid Organ Transplant Recipients and Candidates who Need Immune Checkpoint Inhibitors.

"How I Do it": Caring for Solid Organ Transplant Recipients and Candidates who Need Immune Checkpoint Inhibitors.

Journal: Transplantation

Published: August 11, 2026

Comparing the Effectiveness and Safety of Different Third-Line Management Options for Patients with Metastatic Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis.

Comparing the Effectiveness and Safety of Different Third-Line Management Options for Patients with Metastatic Colorectal Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-Analysis.

Journal: Cancers

Published: June 08, 2026

Prognostic Impact of Baseline Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Prognostic Impact of Baseline Circulating Tumor DNA (ctDNA) in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Journal: Cancers

Published: June 08, 2026

Comprehensive Safety and Efficacy Evaluation of Immunotherapy Combination Approaches Versus Tyrosine Kinase Inhibitor Monotherapy as First-Line Treatment of Hepatocellular Carcinoma: A Network and Individual Patient Data (IPD) Meta-Analysis.

Comprehensive Safety and Efficacy Evaluation of Immunotherapy Combination Approaches Versus Tyrosine Kinase Inhibitor Monotherapy as First-Line Treatment of Hepatocellular Carcinoma: A Network and Individual Patient Data (IPD) Meta-Analysis.

Journal: Cancers

Published: June 07, 2026

MerTK Is Regulated by Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 in Colon Cancer Cells.

MerTK Is Regulated by Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 in Colon Cancer Cells.

Journal: Cancers

Published: May 21, 2026

Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial.

Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trial.

Journal: Future oncology (London, England)

Published: May 04, 2026

Utilization of immunotherapy as a neoadjuvant treatment in liver transplant recipients with hepatobiliary carcinoma.

Utilization of immunotherapy as a neoadjuvant treatment in liver transplant recipients with hepatobiliary carcinoma.

Journal: Frontiers in oncology

Published: April 27, 2026

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions.

Peri-transplant use of immune checkpoint inhibitors in hepatocellular carcinoma: a transplant oncology perspective on safety, timing, post-transplant management, and future directions.

Journal: Frontiers in oncology

Published: March 09, 2026

Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation.

Molecular Profiling of Cholangiocarcinoma Predicts Outcomes Post-Liver Transplantation.

Journal: JCO precision oncology

Published: March 02, 2026

Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma.

Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma.

Journal: Frontiers in transplantation

Published: December 01, 2025

Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitors.

Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitors.

Journal: Immunotherapy

Published: November 21, 2025

Showing 1-12 of 126

Last Updated: 09/26/2026